Claim Missing Document
Check
Articles

Found 2 Documents
Search

The Relationship between Level of D-Dimer Serum with Mortality in Acute Stroke Patiens with COVID-19 Tarmidi, Moch Syahrial Pramudia; Bahrudin, Mochamad
Magna Neurologica Vol. 2 No. 2 (2024): July
Publisher : Department of Neurology Faculty of Medicine Universitas Sebelas Maret

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20961/magnaneurologica.v2i2.955

Abstract

Background: COVID-19 has significantly increased morbidity and mortality in Indonesia, particularly at Gambiran General Hospital in Kediri, East Java, following the WHO's pandemic declaration. The global incidence of acute stroke with COVID-19 is 1.4%, presenting varying clinical features from mild to severe outcomes, and even death. The identification of specific biomarkers, such as elevated D-dimer serum levels, is crucial for predicting severe complications in acute stroke patients with COVID-19. Objective: This study aimed to explore the correlation between elevated levels of mild, moderate, and severe D-dimer serum and mortality in acute stroke patients with COVID-19. Methods: Conducted as an observational analytical study using a cross-sectional approach, this research utilized secondary data from medical records at Kediri Gambiran General Hospital (March 2020 to June 2023). Inclusion and exclusion criteria were applied to hospitalized patients, categorized based on D-dimer levels: normal, mild, moderate, and severe. Statistical analyses, including the Spearman correlation test and Chi-square correlation test, were employed to assess the relationship between D-dimer levels and total mortality. Results: Among the 101 enrolled patients, 53 were male (52.48%), with 90 exhibiting elevated D-dimer levels. Out of these, 44 patients died. The Spearman correlation test showed a non-significant value of 0.069 (p>0.005). The Chi-square correlation test for mild, moderate, and severe D-dimer levels on total mortality also yielded a non-significant value of 0.878. Conclusion: This study found no significant relationship between elevated levels of mild, moderate, and severe D-dimer serum and mortality in acute stroke patients with COVID-19 at Gambiran General Hospital.
D-Dimer Serum Level Association With Mortality In Acute Stroke Patiens With Covid-19 Tarmidi, Moch Syahrial Pramudia; Fitria, Nurul; Giovanni, Oryzasativa; Puspito, Akhdan Zharfan; Arifah, Sintia Wahyu; Akbar, Gibran Maulana
Saintika Medika Vol. 20 No. 2 (2024): December 2024
Publisher : Universitas Muhammadiyah Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22219/sm.Vol20.SMUMM2.33479

Abstract

Background: Since WHO declared COVID-19 a pandemic, Indonesia, including RSUD Gambiran Kediri, has experienced a sharp increase in morbidity and mortality. The global incidence of acute stroke in COVID-19 patients is 1.4%, with symptoms varying from mild to severe, including death. Elevated serum D-dimer in COVID-19 patients can be a biomarker to predict severe complications. Objective: This study aims to determine the relationship between elevated serum D-dimer levels (mild, moderate, severe) with mortality in acute stroke patients with COVID-19. Methods: Observational analytic study with a cross-sectional method using secondary data from medical records of patients admitted to RSUD Gambiran Kediri from March 2020 to June 2023. Patients were categorized based on serum D-dimer levels: normal (<0.5 mg/L), mild (<1 mg/L), moderate (1-2 mg/L), and severe (>2 mg/L). Results: Of 101 acute stroke patients with COVID-19, 52.48% were male. A total of 90 patients had elevated D-dimer levels, with 44 patients dying. Spearman correlation test and Chi-square test showed no significant association between D-dimer levels and mortality (p>0.005). Conclusion: There is no association between elevated serum D-dimer levels and mortality in acute stroke patients with COVID-19.